Table 1 Main characteristics and results of the eligible studies
All studies | NSCLC | SCLC | Neuroendocrine tumours | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Any stage | Locoregional (I–II) | Surgical treatment (I–III) | ||||||||||
Total | S | Total | S | Total | S | Total | S | Total | S | Total | S | |
Number of studies | 28 (25) | 11 (11) | 7 (6) | 2 (2) | 6 (5) | 2 (2) | 8 (7) | 6 (6) | 4 (4) | 0 | 3 (3) | 1 (1) |
